Media headlines about Xtant Medical Holdings (AMEX:XTNT) have been trending negative on Friday, according to Alpha One Sentiment Analysis. The research firm, a subsidiary of Accern, rates the sentiment of media coverage by reviewing more than 20 million blog and news sources. Alpha One ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Xtant Medical Holdings earned a coverage optimism score of -0.35 on Alpha One’s scale. Alpha One also assigned press coverage about the company an impact score of 0 out of 100, meaning that recent media coverage is extremely unlikely to have an impact on the stock’s share price in the next several days.

Separately, Zacks Investment Research downgraded Xtant Medical Holdings from a “buy” rating to a “hold” rating in a report on Saturday, January 7th.

Shares of Xtant Medical Holdings (AMEX:XTNT) opened at 0.59 on Friday. The firm’s market capitalization is $10.67 million. Xtant Medical Holdings has a 12-month low of $0.29 and a 12-month high of $2.65. The company has a 50-day moving average price of $0.60 and a 200-day moving average price of $0.61.

This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at

Xtant Medical Holdings (AMEX:XTNT) last announced its quarterly earnings results on Thursday, March 9th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by $0.01. The company had revenue of $24.47 million for the quarter, compared to the consensus estimate of $24.45 million. Equities analysts predict that Xtant Medical Holdings will post ($1.02) EPS for the current year.

TRADEMARK VIOLATION NOTICE: This report was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at

About Xtant Medical Holdings

Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.

Receive News & Ratings for Xtant Medical Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical Holdings Inc and related companies with's FREE daily email newsletter.